FlyBase curator comment: this entry represents a transgenic construct where the particular construct used cannot be determined.
Expression of DCP2VDRC.cUa under the control of Scer\GAL4elav.PU confers resistance to chronic nicotine-induced locomotor hyperactivity, and also exhibit higher basal locomotor activity without nicotine treatment, as compared to controls.